December 2018

A Paradigm Shift Highlights the Need to Reduce CV Risk in Diabetes

December 27, 2018

Evidence-Based Diabetes Management

From the Editor in Chief of Evidence-Based Diabetes Management.™ Dr Gabbay is senior vice presdient and chief medical officer of Joslin Diabetes Center in Boston, Massachusetts.

Time for a "New Goalpost" in Cardiovascular Outcomes Trials, Kosiborod Suggests

December 26, 2018

Evidence-Based Diabetes Management

Leading cardiologist Mikhail N. Kosiborod, MD, FACC, FAHA, discusses how the FDA's 2008 guidance requiring cardiovascular outcomes trials has changed the treatment landscape in diabetes care and what expectations might look like going forward.

Clinical Evidence for and Cost-Effectiveness of Advanced Cellular Tissue Products for the Treatment of Diabetic Foot Ulcers

December 22, 2018

Evidence-Based Diabetes Management

An estimated 30 million Americans are living with diabetes. Additionally, 84 million have prediabetes, a condition that will result in type 2 diabetes within 5 years if not properly treated. Long regarded as one of the most prevalent chronic diseases in United States, diabetes is also a leading cause of disability and the seventh-leading cause of death. Less discussed is one of the most common complications of diabetes: diabetic foot ulcers. If not properly treated with standard and adjunctive care, these chronic wounds can lead to permanent disability and premature death.